 |
|
Protein deficit impedes recovery after percutaneous angioplasty
January 24, 2003If the body contains too little of the protein haptoglobin, the recovery of the blood vessels after percutaneous angioplasty is impeded. The Utrecht researcher Mirjam Smeets suspects that this is one of the reasons why 40 percent of patients who have undergone percutaneous angioplasty experience a new constriction.
After percutaneous angioplasty, in which occluded vessels are stretched open with a small balloon, 40 percent of patients are rehospitalised with a new constriction of the same vessel. In order to develop drugs against this new vessel constriction, Smeets investigated the processes which occur during the constriction of the vessel wall.
Smeets discovered that the protein haptoglobin inhibits certain enzymes involved in the breakdown of collagen. Collagen is the substance which stiffens the vessel walls. If after percutaneous angioplasty the vessel wall becomes constricted again, there is an increased production and breakdown of collagen.
Moreover, the medical researcher discovered that haptoglobin is produced locally, i.e. in the vessel wall. It was already known that the liver (thus not locally) produces this protein on a large scale and secretes it into the blood.
Furthermore, in cell cultures it has been demonstrated that haptoglobin plays an important role in the migration of cells. Cells which do not produce the protein, migrate less easily. The addition of haptoglobin to these cells enables them to migrate more easily, which results in an improved recovery of damaged blood vessels.
Damaged arteries from mice which cannot produce haptoglobin, recover less well than those from mice which can. Meanwhile a follow-up study has demonstrated that people who cannot produce haptoglobin do not have an increased risk for arteriosclerosis or the occlusion of blood vessels following percutaneous angioplasty.
Knowledge acquired about the mechanism by which damaged blood vessels recover, should eventually lead to the development of drugs that prevent 40 percent of patients from being rehospitalised with a constriction of the same blood vessel following percutaneous angioplasty.
The research was funded by the Netherlands Organisation for Scientific Research (NWO).
NWO (Netherlands Organization for Scientific Research)
Moreover, the medical researcher discovered that haptoglobin is produced locally, i.e. in the vessel wall. It was already known that the liver (thus not locally) produces this protein on a large scale and secretes it into the blood.
Furthermore, in cell cultures it has been demonstrated that haptoglobin plays an important role in the migration of cells. Cells which do not produce the protein, migrate less easily. The addition of haptoglobin to these cells enables them to migrate more easily, which results in an improved recovery of damaged blood vessels.
Damaged arteries from mice which cannot produce haptoglobin, recover less well than those from mice which can. Meanwhile a follow-up study has demonstrated that people who cannot produce haptoglobin do not have an increased risk for arteriosclerosis or the occlusion of blood vessels following percutaneous angioplasty.
Knowledge acquired about the mechanism by which damaged blood vessels recover, should eventually lead to the development of drugs that prevent 40 percent of patients from being rehospitalised with a constriction of the same blood vessel following percutaneous angioplasty.
The research was funded by the Netherlands Organisation for Scientific Research (NWO).
NWO (Netherlands Organization for Scientific Research)
Angioplasty Current Events and Angioplasty News RSSPresence of gum disease may help dentists and physicians identify risk for cardiovascular disease
Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease.
Ultrasound waves aid in rapid treatment of DVT
The use of ultrasound waves for deep vein thrombosis (DVT) may help dissolve blood clots in less time than using clot-busting drugs alone, according to researchers at Emory University.
Nontoxic nanoparticle can deliver and track drugs
A nontoxic nanoparticle developed by Penn State researchers is proving to be an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery.
Dual treatment for stroke leads to improved recovery rates, reduced mortality
It appears that stroke patients who receive both intravenous thrombolysis - a minimally invasive treatment that dissolves abnormal blood clots - and endovascular interventions - such as drugs and implanting medical devices - are much more likely to recover and have lower chances of dying.
Quintet of proteins forms new, early-warning blood test before heart attack strikes
A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.
Hospital rankings: More than meets the eye
Medicare's pay-for-performance program ranks and rewards hospitals according to how well they meet certain guidelines for clinical care.
Study shows safety and efficacy of blood flow reversal system used during carotid stenting
Results of a study on an embolic protection system during carotid stenting that uses a novel blood flow reversal system was reported today during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trial
Late-breaking data from the HORIZONS AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction) trial reveal that after one year, use of a drug-eluting (paclitaxel) stent demonstrated significantly reduced rates of target lesion revascularization (TLR) and binary angiographic restenosis when compared to the use of a bare metal stent in heart attack patients.
HORIZONS AMI will help set guidelines for drug and stent therapy
The HORIZONS AMI clinical trial measuring the safety and efficacy of the use of the medication bivalirudin compared to standard drug therapy - heparin and glycoprotein IIb/IIIa inhibitors -- in heart attack patients who receive angioplasty, found that after 1 year, use of bivalirudin resulted in significantly lower rates of all-cause death, death from cardiac causes, and major bleeding.
Stress tests to confirm need for cardiac stent not occurring in most patients, new study finds
UCSF researchers investigating the appropriate use of procedures to open narrowed coronary arteries -- such as angioplasty and stenting -- found that less than half of Medicare patients had documented noninvasive stress testing prior to elective percutaneous coronary intervention, or PCI, the clinical name for such procedures.
More Angioplasty Current Events and Angioplasty News Articles
 | Vascular Interventional Radiology: Angioplasty, Stenting, Thrombolysis and Thrombectomy (Medical Radiology / Diagnostic Imaging) This volume focusses on the current evidence surrounding the use of endovascular therapy. It updates and complements the earlier Medical Radiology volume on the Radiology of Peripheral Vascular Diseases. Some background information is provided on vascular biology and the facilities required for safe endovascular practice, along with guidance on consent issues. Further chapters deal with... |
 | Complications of Coronary Angioplasty (Fundamental and Clinical Cardiology Series 3) by Black Discusses the subject of the complications of elective coronary angioplasty in detail, primarily for angioplasty operators and cardiologists who are involved in the care of patients with coronary artery disease. The early chapters deal with what has been learned about angioplasty and its... |
 | So You're Having a Heart Cath and Angioplasty by Magnus, MD Ohman, Gail, RN Cox, Stephen, MD Fort, Victoria K., RN Foulger This book is the ultimate guide to cardiac catheterization (heart cath) and angioplasty in the US. It gives you the information you need to be firmly in the driver's seat, from preparing for the first hospital visit, through the heart cath and angioplasty procedures, to the quickest routes to recovery. Real-life patient stories, extensive self-help sections, and detailed illustrations fully... |
 | Angioplasty & Stenting, Understanding |
 | Primary Angioplasty in Acute Myocardial Infarction: Second Edition (Contemporary Cardiology) In the second edition of his widely acclaimed and definitive book, James Tcheng and a panel of authorities have thoroughly updated and revised the first edition with fresh perspectives and the latest scientific and clinical developments in primary percutaneous coronary intervention (PCI). This edition addresses the relentless movement toward stent implantation during PCI, while incorporating the... |
| Infrainguinal Percutaneous Transluminal Angioplasty in Limbs With Severe Lower Limb Ischaemia (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1060) by Anne-Marie Lofberg | |
| Gale Encyclopedia of Medicine: Angioplasty by BSRT, RT(R) Elaine R. Proseus MBA/TM The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major... | |
| Coronary Angioplasty Tutorial The Second Edition of this popular guidebook to percutaneous transluminal coronary angioplasty (PTCA) incorporates the latest advances in both equipment and methods to provide both a concise, up-to-date introduction to coronary angioplasty for the novice as well as a comprehensive, practical reference for the experienced angiographer. As in the first edition, the emphasis is on the practical... | |
 | Passing on Bypass Using External CounterPulsation : An FDA Cleared Alternative to Treat Heart Disease Without Surgery, Drugs or Angioplasty. SECOND EDITION by George J. Juetersonke Over 58 million Americans have some kind of heart disease. Far too many people are unnecessarily forced into surgery or angioplasty when a safer alternative exists. This book describes External CounterPulsation, which is a painless, non-invasive, successful treatment for patients with heart disease and angina. Pressure cuffs wrapped around a patient's legs and hips squeeze the leg muscles in... |
| Ultrasound Angioplasty (Developments in Cardiovascular Medicine) Catheter-delivered therapeutic ultrasound angioplasty is a new technique for use in the treatment of obstructive vascular disease. The treatment differs from balloon angioplasty in that it has been shown experimentally to cause disintegration of calcific and fibrotic atherosclerotic plaques, thrombus dissolution and arterial vasodilation. In contrast to laser technology, ultrasound systems... |
| © 2008 BrightSurf.com |